Patents by Inventor Christopher Higgs

Christopher Higgs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8740071
    Abstract: A method and system for attenuating a shockwave propagating through a first medium. The method and system may include providing a sensor for detecting a shockwave-producing event, which may include detecting an explosive device or detecting an explosion from an explosive device, determining a direction and distance of the shockwave relative to a defended target, calculating with a computer control a firing plan, and interposing a second medium between the shockwave and a protected asset if cost effective to do so. The second medium may be different from the first medium and the shockwave may be reflected, refracted and dispersed, or absorbed as it passes through the second medium prior to reaching the protected asset, and thus may be attenuated in force as it reaches the protected asset.
    Type: Grant
    Filed: April 17, 2012
    Date of Patent: June 3, 2014
    Assignee: The Boeing Company
    Inventors: Christopher Higgs, Brian J. Tillotson
  • Publication number: 20090192138
    Abstract: The invention provides novel deazaxanthine and deazahypoxanthine compounds. The compounds may be useful in the therapy of diseases and conditions in which dipeptidylpeptidase-IV (DPP-IV) is implicated.
    Type: Application
    Filed: December 20, 2006
    Publication date: July 30, 2009
    Inventors: Daniel Kaspar Baeschlin, David Edward Clark, Stephen John Dunsdon, Garry Fenton, Amanda Fillmore, Neil Victor Harris, Christopher Higgs, Christopher Antony Hurley, Sussie Lerche Krintel, Robert Edward Mackenzie, Nils Ostermann, Finton Sirockin, Jonathan Mark Sutton
  • Publication number: 20080269239
    Abstract: The present invention relates to novel pyrimidine compounds, for the modulation of the histamine H4 receptor and the treatment or prevention of conditions mediated by the histamine H4 receptor. The invention also relates to the preparation of such compounds.
    Type: Application
    Filed: November 11, 2005
    Publication date: October 30, 2008
    Applicant: Argenta Discovery Ltd.
    Inventors: Neil Harris, Christopher Higgs, Stephen Wren, Hazel Dyke, Steven Price, Sue Cramp